(A, B), analysis of the succinate:coenzyme Q reductase (SQR) enzymatic activity of complex II. In (A), representative spectrophotometric traces performed on SAOS-2 mitochondria are reported. In (B), analysis of the succinate:coenzyme Q reductase (SQR) enzymatic activity of complex II on HCT116 mitochondria. In the left part, representative spectrophotometric traces are reported; in the right part, analysis was performed as in Figure 3D . The TRAP1 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) was added 5 min before starting recordings. In (C), spectrophotometric analysis of the COX enzymatic activity was performed on SAOS-2 cells. In order to re-express TRAP1 in interfered cells in a shRNA-insensitive way, shTRAP1 cells obtained with sequence b), which is highly divergent between human and mouse genes, were transfected with a mouse TRAP1 cDNA (Origene). HIF1 stable interference was achieved with the following HIF1 shRNAs from Sigma:
CCGGCCAGTTATGATTGTGAAGTTACTCGAGTAACTTCACAATCATAACTGGTTTTT;
CCGGTGCTCTTTGTGGTTGGATCTACTCGAGTAGATCCAACCACAAAGAGCATTTTT;
HIF1 interference was achieved with the following shRNAs from Sigma:
CCGGGCCTACACTCTCCAACACAATCTCGAGATTGTGTTGGAGAGTGTAGGCTTTTT;
CCGGCATTGTCCAGAGGGCTATTAACTCGAGTTAATAGCCCTCTGGACAATGTTTTT;
scrambled shRNAs were always used as negative controls. Stable interfered cells were selected in 0.8 g/ml puromycin (Sigma). TRAP1 mutant lacking the mitochondrial import sequence (N TRAP1) was a Δ1-59-Myc construct generated as in (Amoroso et al., 2012) . MEF cells were transfected with Lipofectamine 2000 (Invitrogen) and selected in G418 (0.5 mg/ml; Sigma) for the expression of TRAP1 cDNA (cloned in a pCMV6 vector, Origene). The rate of cell growth was measured with a Scepter TM cell counter (Millipore).
Tissue Samples
Specimens from both tumor and normal, non-infiltrated peritumoral mucosa were obtained from patients with colorectal carcinoma during surgical cancer removal, after an expressed written informed consent to use biological specimens for investigational procedures was obtained from all patients. Samples were cut into 125 mm 3 pieces and one specimen was fixed in formalin to confirm the histopathological diagnosis, while the others were frozen in liquid nitrogen for further analyses.
TRAP1 expression was evaluated by Western immunoblot followed by densitometric analysis, and its level, which was considered as induced when the ratio between tumor and non-infiltrated surrounding mucosa was ≥3 (Costantino et al., 2009) , increased in all samples from metastatic neoplasias and in the majority of initial, non-metastatic tumors . For ETC complex II evaluations, at least three samples with increased TRAP1 expression and three samples without any TRAP1 expression changes were analyzed.
In Vitro Tumorigenesis Assays
For the focus-forming assay, 10 6 cells were plated in 10 cm Petri dishes (BD Falcon) in Dulbecco's modified Eagle's (DMEM) medium supplemented with 10% fetal bovine serum (Gibco After washing in deionized water, size and number of foci were analyzed with an Image Analyzer custom software (Rasola et al., 2007) . For the soft agar assay, cells were grown in 6 cm Petri dishes covered by a bottom layer composed by DMEM medium mixed with low melting point agarose (Promega) at a final concentration of 1.0%, and by a top layer of DMEM medium supplemented with 0.5% serum and mixed with low melting point agarose at a final concentration of 0.6%. Cells (3x10 5 ) were added during the preparation of the upper layer, where they remained embedded.
Dishes were then maintained in a humidified atmosphere of 5% CO 2 -95% air at 37°C for three weeks, adding medium (DMEM 0.5% serum) on the top of the two layers every 7 th day. At the 25 th day, dishes were washed in PBS and colonies were stained with Crystal Violet 0.005% and analyzed with Image Analyzer software.
In Vivo Tumorigenesis Assays
Experiments were performed in 5-week-old female CD1 nude mice (Charles River Laboratories) treated in accordance with the European Community guidelines. Twelve mice were injected subcutaneously bilaterally in the flanks with 1.5x10 7 SAOS-2 mock or shTRAP1 cells in 200 l of serum-free sterile PBS. In a subset of animals, tumor growth was favored by injecting cells in PBS mixed with Matrigel in a 1:1 ratio. Tumor growth was evaluated on alternate days by calliper measuring. After three weeks, mice were sacrificed and tumors stored at -80°C or fixed in formaldehyde and maintained in 70% ethanol for immunohistochemical analyses.
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Cytofluorimetric Analyses
Flow cytometry recordings were performed to determine cell death, as described (Fassetta et al., 2006; Gramaglia et al., 2004) , and mitochondrial mass. Briefly, cells were incubated at 37°C in 135 mM NaCl, 10 mM HEPES, 5 mM CaCl 2 with FITC-conjugated Annexin-V (Boehringer Mannheim) and propidium iodide (PI, 1 g/ml; Sigma), to detect phosphatidyl-serine exposure on the cell surface (increased FITC-conjugated Annexin-V staining) and loss of plasma membrane integrity (PI permeability and staining). N-acrydine orange (NAO 200 nM, Invitrogen), which binds to cardiolipin in mitochondrial membranes, was utilized to evaluate mitochondrial mass. Samples were analyzed on a FACS Canto II flow cytometer (Becton Dickinson). Data acquisition and analysis were performed using FACSDiva software.
Mitochondria Purification and Quantification
Mitochondria were isolated after cell disruption with a glass-Teflon or electrical potter (Sigma) in a buffer composed by 250 mM sucrose, 10 mM Tris-HCl, 0.1 mM EGTA-Tris, pH 7.4. Nuclei and plasma membrane fractions were separated by a first mild centrifugation (700g, 10 min); mitochondria were then spinned down at 7000g, 10 min, and washed twice (7000g, 10 min each).
All procedures were carried out at 4°C. In order to define submitochondrial protein localization, isolated mitochondria were digested with trypsin at different concentrations at 4°C for 1h. Where indicated, 0.1% SDS was added before trypsin. Trypsin was then inactivated with a protease inhibitor cocktail (Sigma).
Western Immunoblots, Immunoprecipitations and Crosslinkings
For Western immunoblots analyses, cells kept in standard culture conditions or in focus-forming assays were lysed at 4°C in a buffer composed by 140 mM NaCl, 20 mM Tris-HCl pH 7.4, 5 mM EDTA, 10% glycerol, 1% Triton X-100, in the presence of phosphatase and protease inhibitors (Sigma). Lysates were then cleared with a centrifugation at 13000g for 30 min at 4°C, and proteins were quantified using a BCA Protein Assay Kit (Thermo Scientific-Pierce).
Protein immunoprecipitations were carried out on 3 mg of total cellular extracts. Lysates were pre-cleared with an incubation with protein A-Sepharose (Sigma) for 1 h at 4°C and then incubated in agitation for 18 h at 4°C with the antibody conjugated to fresh protein A-Sepharose beads. Where indicated, an anti mouse IgG was added as a negative isotype control. Beads were then washed several times in lysis buffer.
For the crosslinking assays, isolated mitochondria were suspended in PBS buffer and incubated with dimethyl 3,3-dithiobis-propionimidate (DTBP, Sigma, 1 mM), a membranepermeable, homo-bifunctional reagent that reacts with the primary amines of two interacting proteins at an average distance of about 8 Å (Giorgio et al., 2009 ), for 15 minutes at room temperature and then spinned at 7000 rcf for 5 minutes. Pellet was then lysed as above, and lysates were ultracentrifuged at 100000 rcf for 25 minutes at 4°C prior to TRAP1 immunoprecipitation.
Proteins extracted from total cell lysates or from immunoprecipitations were then boiled for 
ETC Complex II and IV Activity Assays
To measure the enzymatic activity of respiratory chain complex II, cells or biopsies were homogenized with an electric potter (Sigma) in a buffer composed by 250 mM sucrose, 10 mM
Tris-HCl, 0.1 mM EGTA-Tris, pH 7.4, Percoll 10%, protease and phosphatase inhibitors and mitochondria isolated as described above. Mitochondrial enriched fractions (40 g per trace) were 13 used for spectrophotometric recordings (600 nm, 30°C) of the reduction of 2-6 dichlorophenolindophenol (DCPIP). Mitochondria are preincubated for 10 min at 30°C in a buffer composed by potassium phosphate 25 mM pH 7.2, sodium succinate 20 mM, alamethicin 5 M.
After the pre-incubation time, sodium azide (500 M), antimycin A (1 M), rotenone (1 M) and DCPIP (50 M) were added for 1 min to the medium. Reaction started after the addition of an intermediate electron acceptor (Coenzyme Q1, 6.5 M). Each measurement of ETC complex II activity was normalized for citrate synthase (CS) activity. To measure CS activity, citrate formation is determined with a spectrophotometer as an increase in absorbance at 420 nm, 37°C. Reaction buffer was composed by 100 mM Tris-HCl pH 8, 100 M DTNB, 300 M Acetyl -CoA, 500 M Oxaloacetate.
To measure the enzymatic activity of respiratory chain Complex IV, cells were subjected to three cycles of freezing and thawing in liquid nitrogen. These cellular homogenates were used for spectrophotometric recordings (550 nm, 37°C) of the oxidation of reduced cytochrome c, (ε=18.5 mM−1 cm−1) in a buffer composed by potassium phosphate 100 mM pH 7, water and laurylmaltoside 10% p/v. The reaction started by the addition of cellular homogenates and the decrease in absorbance was followed for 3 min. Reduced cytochrome c was prepared immediately before use by adding a few grains of sodium dithionite. Each measurement of ETC complex IV activity was normalized for protein amount and for CS activity, as above.
Oxygen Consumption Rate Experiments
The rate of oxygen consumption was assessed in real-time with the XF24 Extracellular Flux Analyzer (Seahorse Biosciences), which allows to measure OCR changes after up to four sequential additions of compounds. Cells (5x10 4 /well) were plated the day before the experiment in a DMEM/10% serum medium; experiments were carried out on confluent monolayers. Before starting measurements, cells were placed in a running DMEM medium (supplemented with 25 mM
Determination of Intracellular Succinate Level
To determine the intracellular succinate level, cells were first washed three times in PBS at room temperature and then quickly scraped in a buffer composed by 30% acetonitrile, 50% methanol and 20% water on ice. Lysates were collected and frozen in a cold solution with methanol and dry ice for 5 min in order to favor the metabolic quenching needed for metabolites extraction. The insoluble material was immediately spun down in a cooled centrifuge at 16000 g for 15 min at 0°C and the supernatant was collected for subsequent analysis. Metabolites were separated using a liquid chromatography (LC) system and analyzed by mass spectrometry (MS). A ZIC-HILIC column (4.6 mm×150 mm, guard column 4.6 mm×10 mm, Merck, Germany) was used for LC separation using formic acid, water acetonitrile as component of the mobile phase. Results were normalized to protein concentration, measured from parallel cell culture using BCA kit as described above.
Intracellular ATP Determination
Intracellular ATP was quantified by the luciferin/luciferase method using the ATP determination kit by Invitrogen/Molecular Probes following manufacturer's instructions. Cells were kept for two hours in the different experimental conditions, washed in PBS, lysed in boiling water to avoid ATPase activity. 2.5 g of proteins were analyzed in a 100 l final volume. Each experiment was performed in triplicate.
